The authors regret that following relevant citations, acknowledgments and data availability information were inadvertently omitted:
1) The citations below include important technical details on the processing of the blood samples:
Arnold, M., Nho, K., Kueider-Paisley, A., Massaro, T., Brauner, B., MahmoudianDehkordi, S., Louie, G., Moseley, M.A., Thompson, J.W., Williams, L.S.J., 2019. The Alzheimer’s Disease Metabolome: Effects of Sex and APOE ε4 genotype. bioRxiv 585455.
St John-Williams, L., Blach, C., Toledo, J.B., Rotroff, D.M., Kim, S., Klavins, K., Baillie, R., Han, X., Mahmoudiandehkordi, S., Jack, J., others, 2017. Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. Sci. data 4, 170140.
Toledo, J.B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R.A., Han, X., Thambisetty, M., Tenenbaum, J.D., Suhre, K., Thompson, J.W., others, 2017. Metabolic network failures in Alzheimer’s disease: A biochemical road map. Alzheimers Dement. 13, 965–984.
2) Additional Acknowledgments:
The results published here are based on metabolomics data generated by the Alzheimer’s Disease Metabolomics Consortium (ADMC; ADMC members list https://sites.duke.edu/adnimetab/team/), led by Dr. Rima Kaddurah-Daouk at Duke University, using biospecimens provided by the Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago. Support for the biospecimen processing and data generation conducted by the ADMC was provided by the following National Institute on Aging grants R01AG046171, RF1AG051550, RF1AG057452, RF1AG059093, RF1AG058942, U01AG061359, and the Foundation for the NIH (FNIH) grant: #DAOU16AMPA.
3) Data Availability/Data Citation information:
The metabolomics datasets and relevant metadata used in the analyses described in this manuscript can be accessed via the AMP-AD Knowledge Portal (ROSMAP brain p180, https://doi.org/10.7303/syn10235595 and ROSMAP serum p180 https://doi.org/10.7303/syn10235596).